Xinhua Ji, Ph.D.

Xinhua  Ji, Ph.D.
Senior Investigator
Head, Biomolecular Structure Section

Dr. Ji pioneered the structural analysis of double-stranded RNA (dsRNA) in complex with RNase III enzymes. Over the past decade, he has provided the structural view of dsRNA processing by bacterial RNase III. Recently, his structure of a eukaryotic RNase III has revealed a picking motif in structured RNA and a double-ruler mechanism for substrate selection.

As Head, Dr. Ji directs the Section’s basic and translational research program that is focused on the structural biology of RNA biogenesis, especially post-transcriptional RNA processing, and structure-based development of anticancer and antimicrobial agents.

Areas of Expertise

1) X-ray crystallography, 2) structural biology, 3) chemical biology, 4) structure-based
drug design, 5) RNA biogenesis, 6) RNase III enzymes

Contact Info

Xinhua Ji, Ph.D.
Center for Cancer Research
National Cancer Institute
BG 538, RM 207
Frederick, MD 21701
Ph: 301-846-5035

Biomolecular Structure and Mechanism, Structure-Based Drug Design

Our research is focused on the structural biology of RNA biogenesis, with an emphasis on RNA-processing proteins and RNA polymerase-associated transcription factors, and structure-based development of therapeutic agents. The goal of structural analysis is to map the reaction trajectory or functional cycle of selected biological macromolecules, and that of drug discovery is to design, synthesize, and characterize novel anticancer and antimicrobial agents. To date, we have characterized the reaction trajectory and/or functional cycle of HPPK (a folate pathway enzyme essential for microorganisms but absent in mammals, View), Era (an essential GTPase that couples cell growth with cell division, View), RapA (a Swi2/Snf2 protein that recycles RNA polymerase, View), bacterial RNase III, and yeast RNase III (Rnt1p). Several biomolecules mentioned above are attractive molecular targets and structure-based drug development is an integral part of our research. See our Science Gallery and Drug Discovery Patents for the scope and depth of our science. Our contributions of RNase III research is summarized.

RNase III (ribonuclease III) enzymes, exemplified by prokaryotic RNase III and eukaryotic Rnt1p, Dcr1, Dicer, and Drosha, play important roles in RNA processing and maturation, post-transcriptional gene silencing, and defense against viral infection. For mechanistic studies, bacterial enzyme is a valuable model system for the entire family. We have shown how the dimerization of the  RNase III endonuclease domain (RIIID) creates a catalytic valley where  two cleavage sites are located, how the catalytic valley accommodates a dsRNA in a manner such that each of the two RNA strands is aligned with one of the two cleavage sites, how the  hydrolysis of each strand involves both RIIIDs, and how RNase  III uses the two cleavage sites to create the 2-nucleotide 3' overhangs in its products (View). We have also shown how magnesium is essential for the formation of a catalytically competent protein-RNA complex, how the use of two magnesium ions can drive the hydrolysis of each phosphodiester bond, and how conformational changes in both the substrate and the protein are critical elements for assembling the catalytic complex. Moreover, we have provided a stepwise mechanism for the enzyme to execute the phosphoryl transfer reaction (View). As informative as the bacterial enzyme for the mechanism of RNase III action, yeast Rnt1p is a valuable model system for eukaryotic RNase III enzymes. Unlike bacterial enzymes that use four catalytic side chains, eukaryotic RNase IIIs use six. It is also distinguished from bacterial enzymes that every eukaryotic RNase III has an N-terminal extension. What is more, Rnt1p exhibits a strict guanine nucleotide specificity, which is unique among RNase III enzymes. We have shown how the substrate-binding mode of Rnt1p is  distinct from that of bacterial RNase III (View), how all of the six catalytic side chains are engaged in the cleavage site (View), how a new RNA-binding motif of Rnt1p functions as a guanine-specific clamp (View), and how the double-stranded RNA-binding domain and N-terminal domain of Rnt1p  function as two rulers measuring the distance between the guanine nucleotide to the cleavage sites (View). This unusual mechanism of substrate selectivity represents an example of the evolution of substrate selectivity and provides a framework for understanding the mechanism of action of other eukaryotic RNase  III enzymes, including Dcr1, Dicer, and Drosha.

The worldwide effort in structural analysis of other eukaryotic RNase III enzymes resulted in several important structures, including the crystal structures of Dicer (View), Dcr1 (View), and Drosha (View). These structures, however, do not contain RNA and thus are not able to explain their mechanisms of action. Our structures of RNase III:dsRNA complexes greatly enhanced the significance of these important structures. Based on the protein-RNA interactions revealed by our structures of RNase III and Rnt1p, models with RNA can be reliably constructed for Dicer, Dcr1, and Drosha. A model complex of Dicer with RNA explains how Dicer enzymes recognize the 2-nucleotide 3' overhang of dsRNA substrate and measure 22 nucleotides up to position the scissile bond over the cleavage site. A model complex of Dcr1 with RNA explains how homodimers of non-canonical Dicer enzymes bind cooperatively along dsRNA substrate such that the distance between active centers in adjacent homodimers is the length of 22 nucleotides. A model complex of Drosha with RNA explains how Drosha enzymes recognize the last base pair in the basal junction of the primary microRNA substrate and measure 11 nucleotides up to position the scissile bond over the cleavage site.

NIH Scientific Focus Areas:
Cancer Biology, Chemical Biology, Microbiology and Infectious Diseases, Molecular Biology and Biochemistry, Structural Biology
  1. Song H, Ji X
    Nature Communications. 10(1): 3085, 2019. [ Journal Article ]
  2. Jin L, Song H, Tropea JE, Needle D, Waugh DS, Gu S, Ji X.
    Nucleic Acids Res. 47(9): 4707-4720, 2019. [ Journal Article ]
  3. Wang C, Shi G, Ji X
    MedChemComm. 9(11): 1818-1825, 2018. [ Journal Article ]
  4. Abou Elela S, Ji X.
    Wiley Interdiscip Rev RNA. 10(3): e1521, 2018. [ Journal Article ]
  5. Court DL, Gan J, Liang YH, Shaw GX, Tropea JE, Costantino N, Waugh DS, Ji X.
    Annu Rev Genet. 47: 405-431, 2013. [ Journal Article ]

Dr. Ji earned his Ph.D. degree at the University of Oklahoma (1985-1990) and performed his postdoctoral research at the University of Maryland (1991-1994), where he became a Research Assistant Professor (1994-1995) before joining the National Cancer Institute (NCI), National Institutes of Health (NIH). At the NCI at Frederick, Dr. Ji established his laboratory in the ABL-Basic Research Program in 1995, moved to the Center for Cancer Research in 1999, gained tenure in 2001 as an NIH Senior Investigator, and in 2008 became a member of the Senior Biomedical Research Service (SBRS). The SBRS, established under the Public Health Service Act, was created for scientists who are considered by their peers to be outstanding in their work.

Name Position
Sudhaker Dharavath Ph.D. Postdoctoral Fellow (Visiting)
Lan Jin Ph.D. Research Fellow
Anjana Ram Postbaccalaureate Fellow (CRTA)
Joshua S. Rose Ph.D. Postdoctoral Fellow (CRTA)
Gary Shaw Ph.D. Research Biologist
Genbin Shi, Ph.D. Staff Scientist

Dr. Chao Wang


Photo NCI-CCR-MCL Dr. Lan JinDr. Lan Jin 

  • Recipient of the Poster Award at the NCI Structural Biology Retreat for her outstanding presentation entitled “The Molecular Mechanism of dsRNA Processing by a Bacterial Dicer” (2018).


Dr. Smita Kakar

  • Recipient of the Poster Award at the NCI Structural Biology Retreat for outstanding presentaton of her work as shown below (2015).

Dr. Yu-He Liang

Dr. Jason Stagno

Dr. Chao Tu

  • WINNER of the NIH Fellows Award for Research Excellence (FARE) 2010 competition for his work entitled “Structure of ERA in complex with the 3′ end of 16S rRNA: Implications for ribosome biogenesis” (2009).
  • Winner of The Outstanding Scientific Presentation Award for his talk entitled “ERA: a GTP-dependent Molecular Switch Recognizes the 3’ End of 16S rRNA” in the Chemistry as a Life Science Symposium at the National Cancer Institute’s Spring Research Festival at Frederick (2009).
  • Selected to receive The Protein Society Young Investigator Award, Protein Society Young Investigator Travel Grant, and The Protein Society Finn Wold Travel Award with an invited talk entitled “Structure of ERA in complex with the 3′ end of 16S rRNA: Implications for ribosome biogenesis” (2009).

Dr. Jianhua Gan

Dr. Bing Xiao

Dr. Jaroslaw Blaszczyk